Quest Diagnostics Inc (DGX): Today's Featured Health Services Winner
Quest Diagnostics (DGX) pushed the Health Services industry higher today making it today's featured health services winner. The industry as a whole closed the day down 0.7%. By the end of trading, Quest Diagnostics rose 40 cents (0.7%) to $56.99 on average volume. Throughout the day, 687,082 shares of Quest Diagnostics exchanged hands as compared to its average daily volume of 915,700 shares. The stock ranged in a price between $56.51-$57.48 after having opened the day at $56.51 as compared to the previous trading day's close of $56.59. Other companies within the Health Services industry that increased today were: Urologix (ULGX), up 19.5%, Dynacq Healthcare (DYII), up 13.4%, Gentiva Health Services (GTIV), up 11.8%, and SRI Surgical Express (STRC), up 8.1%. Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. Quest Diagnostics has a market cap of $9.08 billion and is part of the health care sector. The company has a P/E ratio of 13.5, equal to the average health services industry P/E ratio and below the S&P 500 P/E ratio of 17.7. Shares are down 2.5% year to date as of the close of trading on Monday. Currently there are three analysts that rate Quest Diagnostics a buy, one analyst rates it a sell, and 13 rate it a hold. TheStreet Ratings rates Quest Diagnostics as a buy. The company's strengths can be seen in multiple areas, such as its compelling growth in net income, revenue growth, expanding profit margins, notable return on equity and solid stock price performance. We feel these strengths outweigh the fact that the company has had generally poor debt management on most measures that we evaluated.
- You can view the full Quest Ratings Report.
- Use our health services section to find industry-relevant news.
- Or find some new ideas from our top rated stocks lists.
- Find other investment ideas from our top rated ETFs lists.
Latest Headlines about DGX
-
July Options Now Available For Quest Diagnostics (DGX)
06:40PM 05/20/13
-
The Long Term GARP Portfolio Delivers In April
05:52AM 05/20/13
-
DGX Crosses Above Key Moving Average Level
04:13PM 05/08/13
-
The New #53 Most Shorted S&P 500 Component: Quest Diagnostics
03:59PM 04/25/13
-
Sometimes Less Is More When It Comes To Investing
09:24PM 03/26/13
-
5 Stocks Spiking on Big Volume
03:58PM 01/18/13
-
5 Dividend Stocks Ready to Boost Payouts
01:14PM 09/25/12
Latest from TheStreet Wire
-
Infosys Ltd (INFY): Today's Featured Technology Laggard
05:01PM 05/24/13
-
Williams Companies Inc (WMB): Today's Featured Basic Materials Laggard
05:01PM 05/24/13
-
Trimble Navigation Limited (TRMB): Today's Featured Electronics Laggard
05:01PM 05/24/13
-
Deere & Co (DE): Today's Featured Industrial Laggard
05:01PM 05/24/13
-
Eli Lilly And Company (LLY): Today's Featured Drugs Laggard
05:01PM 05/24/13
-
Sap AG (SAP): Today's Featured Computer Software & Services Laggard
05:01PM 05/24/13
-
Duke Energy Corporation (DUK): Today's Featured Utilities Laggard
05:01PM 05/24/13
Select the service that is right for you!
COMPARE ALL SERVICESAction Alerts PLUS
TRY IT FREEJim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
Product Features:
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Dividend Stock Advisor
TRY IT FREENew! $49.95/yr
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Product Features:
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREEDavid Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Product Features:
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
- Weekly roundups
Real Money
TRY IT FREE24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.
Product Features:
- Jim Cramer + 20 Wall Street pros
- Intraday commentary & news
- Real-time trading forum
- Actionable trade ideas
Real Money Pro
TRY IT FREEAll of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Product Features:
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Options Profits
TRY IT FREEOur options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
Product Features:
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV
